These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Shah AR; Agarwal SK; Shah KV Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118 [TBL] [Abstract][Full Text] [Related]
29. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)]. Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253 [No Abstract] [Full Text] [Related]
30. Drug resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001. Vásquez-Campos L; Asencios-Solis L; Leo-Hurtado E; Quispe-Torres N; Salazar-Lindo E; Bayona J; Becerra MC Int J Tuberc Lung Dis; 2004 Apr; 8(4):465-72. PubMed ID: 15141740 [TBL] [Abstract][Full Text] [Related]
31. Intermittent chemotherapy or improvement of initial treatment in tuberculosis. Oka S Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):1-6. PubMed ID: 4949334 [No Abstract] [Full Text] [Related]
32. [New drugs in antitubercular therapy]. Favez G Helv Med Acta Suppl; 1969; 49():66-80. PubMed ID: 4912509 [No Abstract] [Full Text] [Related]
33. Diseases of the respiratory system: tuberculosis. Seaton A Br Med J; 1978 Mar; 1(6114):701-3. PubMed ID: 630304 [No Abstract] [Full Text] [Related]
34. [Mode of action of "tuverculostatics". Consequences for the therapy]. Krebs A Z Tuberk Erkr Thoraxorg; 1968; 128(1):208-17. PubMed ID: 4973006 [No Abstract] [Full Text] [Related]
35. Consequences of the development of new antituberculous drugs for the treatment of tuberculosis. Freerksen E Antibiot Chemother; 1970; 16():524-9. PubMed ID: 5523735 [No Abstract] [Full Text] [Related]
36. [Effectiveness of chemotherapy of chronic forms of pulmonary tuberculosis under hospital conditions]. Kolesnikov VV; Mikhaĭlov VI; Matviiakina TS Probl Tuberk; 1980 Mar; (3):41-4. PubMed ID: 7393892 [No Abstract] [Full Text] [Related]
37. An overview of tuberculosis in the 1980s. Jones FL Pa Med; 1983 Feb; 86(2):36-40. PubMed ID: 6682542 [No Abstract] [Full Text] [Related]
38. Drug-resistant tuberculosis in Turkish children. Dilber E; Göçmen A; Kiper N; Ozçelik U Turk J Pediatr; 2000; 42(2):145-7. PubMed ID: 10936981 [TBL] [Abstract][Full Text] [Related]
39. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients]. Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895 [No Abstract] [Full Text] [Related]